BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29174367)

  • 1. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
    Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
    Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
    Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
    J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.
    Fiuza-Luces C; Santos-Lozano A; Llavero F; Campo R; Nogales-Gadea G; Díez-Bermejo J; Baladrón C; González-Murillo Á; Arenas J; Martín MA; Andreu AL; Pinós T; Gálvez BG; López JA; Vázquez J; Zugaza JL; Lucia A
    J Physiol; 2018 Mar; 596(6):1035-1061. PubMed ID: 29315579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential glucose metabolism in mice and humans affected by McArdle disease.
    Krag TO; Pinós T; Nielsen TL; Duran J; García-Rocha M; Andreu AL; Vissing J
    Am J Physiol Regul Integr Comp Physiol; 2016 Aug; 311(2):R307-14. PubMed ID: 27280431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
    Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
    Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
    Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
    J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate and Energy Metabolism During Exercise in Patients With Blocked Glycogenolysis (McArdle Disease).
    Ørngreen MC; Jeppesen TD; Taivassalo T; Hauerslev S; Preisler N; Heinicke K; Haller RG; Vissing J; van Hall G
    J Clin Endocrinol Metab; 2015 Aug; 100(8):E1096-104. PubMed ID: 26030324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 5'AMP-activated protein kinase in glycogen synthase activity and glucose utilization: insights from patients with McArdle's disease.
    Nielsen JN; Wojtaszewski JF; Haller RG; Hardie DG; Kemp BE; Richter EA; Vissing J
    J Physiol; 2002 Jun; 541(Pt 3):979-89. PubMed ID: 12068056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of changes in fat availability on exercise capacity in McArdle disease.
    Andersen ST; Jeppesen TD; Taivassalo T; Sveen ML; Heinicke K; Haller RG; Vissing J
    Arch Neurol; 2009 Jun; 66(6):762-6. PubMed ID: 19506137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response effect of pre-exercise carbohydrates under muscle glycogen unavailability: Insights from McArdle disease.
    Valenzuela PL; Santalla A; Alejo LB; Merlo A; Bustos A; Castellote-Bellés L; Ferrer-Costa R; Maffiuletti NA; Barranco-Gil D; Pinós T; Lucia A
    J Sport Health Sci; 2024 May; 13(3):398-408. PubMed ID: 38030066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
    de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
    Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes and exercise intolerance: insights from McArdle disease.
    Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
    Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired glycogen breakdown and synthesis in phosphoglucomutase 1 deficiency.
    Preisler N; Cohen J; Vissing CR; Madsen KL; Heinicke K; Sharp LJ; Phillips L; Romain N; Park SY; Newby M; Wyrick P; Mancias P; Galbo H; Vissing J; Haller RG
    Mol Genet Metab; 2017 Nov; 122(3):117-121. PubMed ID: 28882528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease.
    McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ
    Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat metabolism during exercise in patients with McArdle disease.
    Ørngreen MC; Jeppesen TD; Andersen ST; Taivassalo T; Hauerslev S; Preisler N; Haller RG; van Hall G; Vissing J
    Neurology; 2009 Feb; 72(8):718-24. PubMed ID: 19237700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
    Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
    Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
    Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?
    Villarreal-Salazar M; Santalla A; Real-Martínez A; Nogales-Gadea G; Valenzuela PL; Fiuza-Luces C; Andreu AL; Rodríguez-Aguilera JC; Martín MA; Arenas J; Vissing J; Lucia A; Krag TO; Pinós T
    Mol Metab; 2022 Dec; 66():101648. PubMed ID: 36455789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease.
    Howell JM; Walker KR; Creed KE; Dunton E; Davies L; Quinlivan R; Karpati G
    Neuromuscul Disord; 2014 Feb; 24(2):167-77. PubMed ID: 24309536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle glycogen unavailability and fat oxidation rate during exercise: Insights from McArdle disease.
    Rodriguez-Lopez C; Santalla A; Valenzuela PL; Real-Martínez A; Villarreal-Salazar M; Rodriguez-Gomez I; Pinós T; Ara I; Lucia A
    J Physiol; 2023 Feb; 601(3):551-566. PubMed ID: 36370371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.